Vanguard Group Inc

13F Holdings History for Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

Symbol: RLAY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 9.38M shares
Security Ownership: 5.47%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Relay Therapeutics, Inc. Common Stock, par value $0.0001 per share (RLAY)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.38M shares of Relay Therapeutics, Inc. Common Stock, par value $0.0001 per share (RLAY). This represents 5.47% percent ownership of the company. In their previous filing dated 2025-04-30, VANGUARD GROUP INC had reported owning 12.1M shares, indicating a decrease of -22.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	5.47%	-23.9%	$27.7M	9.38M	-2,725,569	-22.5%	$2.95	13G/A	6/30/2025	29 Jul 2025 14:22:24
The Vanguard Group	7.14%		$29.3M	12.1M			$2.42	13G/A	3/31/2025	30 Apr 2025 11:12:24

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	0%	$32.5M	9.38M	-2,725,569	-22.5%	$3.46	Q2 2025
3/31/2025	0%	0%	$31.7M	12.1M	-2,924,789		$2.62	Q1 2025
12/31/2024	0%	+0%	$61.9M	15M	+566,595	+3.92%	$4.12	Q4 2024
9/30/2024	0%	+0%	$102M	14.5M	+2,758,748	+23.6%	$7.08	Q3 2024
6/30/2024	0%	0%	$76.3M	11.7M	-110,803	-0.94%	$6.52	Q2 2024
3/31/2024	0%	+0%	$98.1M	11.8M	+1,165,282	+10.9%	$8.30	Q1 2024
12/31/2023	0%	+0%	$117M	10.7M	+98,025	+0.93%	$11.01	Q4 2023
9/30/2023	0%	+0%	$88.7M	10.6M	+23,795	+0.23%	$8.41	Q3 2023
6/30/2023	0%	+0%	$132M	10.5M	+29,053	+0.28%	$12.56	Q2 2023
3/31/2023	0%	+0%	$173M	10.5M	+115,296	+1.11%	$16.47	Q1 2023
12/31/2022	0%	+0%	$155M	10.4M	+2,024,698	+24.2%	$14.94	Q4 2022
9/30/2022	0.01%	+0%	$187M	8.36M	+1,261,066	+17.8%	$22.37	Q3 2022
6/30/2022	0%	+0%	$119M	7.1M	+880,831	+14.2%	$16.75	Q2 2022
3/31/2022	0%	+0%	$186M	6.22M	+19,181	+0.31%	$29.93	Q1 2022
12/31/2021	0%	+0%	$190M	6.2M	+1,314,405	+26.9%	$30.71	Q4 2021
9/30/2021	0%	+0%	$154M	4.88M	+590,595	+13.8%	$31.53	Q3 2021
6/30/2021	0%	+0%	$157M	4.29M	+242,361	+5.98%	$36.59	Q2 2021
3/31/2021	0%	+0%	$140M	4.05M	+2,330,406	+135%	$34.57	Q1 2021
12/31/2020	0%	+0%	$71.5M	1.72M	+88,701	+5.44%	$41.56	Q4 2020
9/30/2020	0%	+0%	$69.5M	1.63M	+1,631,974	NEW	$42.59	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.